Tag: Cancer: Misc.

Large differences in risks for severe adverse events according to sex seen for cancer patients receiving immunotherapy

No significant associations seen for spironolactone with risk for breast, ovarian, bladder, kidney, gastric, esophageal cancers

Direct oral anticoagulants reduce recurrent VTE events by 41 percent, with no significant increase in major bleeding, compared to dalteparin

Issues include increased burden of COVID-19 in patients with cancer, lessons from COVID-19 with potential to improve cancer care

Mortality rates 41 percent higher for breast cancer for Black women, despite similar or lower incidence rates compared with Whites

Additionally, rural residents show greater information overload

Among patients with cancer, pain at the injection site was less likely after dose 1 for those receiving active treatment

Risk reduced for gastrointestinal cancers, increased for cancers of neurological origin

Increase also seen in prevalence of multiple chronic conditions for cancer survivors, which was most pronounced among those aged 18 to 44 years

Program aims to reduce cancer death rate by 50 percent during the next 25 years